Massachusetts General Hospital will be able to communicate with physicians and patients to review pathology cases in real time thanks to technology developed by Corista LLC.

Using Corista’s digital platform Massachusetts General Hospital’s Pathology Network will enable its clinical experts to share images with remote patients and their physicians in real time, the Concord-based company announced recently.

Members of the academic pathology department, which provide subspecialty clinical services, will be able to use Corista’s DP3 toolset to provide analysis and diagnosis on images and also generate reports. There are a total of 90 faculty, 800 employees and 50 residents under the direction of Dr. David Lewis, chief of pathology at Massachusetts General Pathology Service, who are responsible for 10 million clinical laboratory tests, 80,000 surgical specimens, 60,000 cytopathology specimens and 35,000 red-cell transfusions each year.

Corista CEO Elizabeth Wingard stated that remote patients and hospitals benefit from its DP3 platform because specialists are able to get immediate responses and therefore improve patient care. Without the real-time capability, information would have been delayed by days using other methods such as couriers and other delivery methods, she added.

Wingard, along with the company’s Managing Director Richard Wingard and CTO Charles Pace, co-founded Corista in 2005. Richard Wingard, who has 25 years in the business of medical imaging and healthcare technology, was the senior executive for Sprint’s healthcare initiatives. He designed and developed Sprint’s healthcare technology capability, HANDS, which set the standard for telemedicine and tele-radiology, according to Corista.

Go here to see the original:
Concord’s Corista helps MGH share images